Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 4584
MIM: 158371
HGNC: 7513
Ensembl: ENSG00000169894
Variants:
dbSNP: 4584
ClinVar: 4584
TCGA: ENSG00000169894
COSMIC: MUC3A
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000169894 | ENST00000379458 | Q02505 |
| ENSG00000169894 | ENST00000414964 | A0A182DWF7 |
| ENSG00000169894 | ENST00000483366 | Q02505 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38069509 | 2023 | Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy. | 0 |
| 38069509 | 2023 | Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy. | 0 |
| 35655161 | 2022 | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway. | 6 |
| 35655161 | 2022 | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway. | 6 |
| 33249400 | 2021 | KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. | 14 |
| 33994852 | 2021 | MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer. | 8 |
| 34326691 | 2021 | MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. | 5 |
| 33249400 | 2021 | KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. | 14 |
| 33994852 | 2021 | MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer. | 8 |
| 34326691 | 2021 | MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. | 5 |
| 30260046 | 2019 | MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma. | 23 |
| 30260046 | 2019 | MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma. | 23 |
| 27374181 | 2016 | Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma. | 14 |
| 27374181 | 2016 | Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma. | 14 |
| 20510874 | 2010 | Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. | 13 |
Citation
Dessen P
MUC3A (mucin 3A, cell surface associated)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/41458/muc3a-(mucin-3a-cell-surface-associated)
